Abstract. thyroid cells express a muscarinic receptor which inhibits the phospholipase C activity in a pirenzepine-insensitive manner. We here report that the cholinergic agonist carbachol decreases in these cells the steady-state iodide content, an effect correlated with the iodination of thyroglobulin and with thyroid hormone formation. Several signal pathways may be involved in this phenomenon since carbachol in addition to inhibiting phospholipase C, increased the arachidonic acid release and modified the adenylyl cyclase activity. In cells, arachidonic acid is released via the direct stimulation of phospholipase A2 by a pirenzepine-sensitive muscarinic receptor coupled to a GTP binding protein sensitive to pertussis toxin. Regarding adenylyl cyclase, carbachol potentiated the thyrotropin-induced stimulation of the enzyme, whereas it did not affect the basal levels of cAMP.
In vitro binding studies revealed the presence of two muscarinic binding sites. To The activation of the muscarinic acetylcholine re¬ ceptor has been associated with the modulation of the cytosolic levels of inositol phosphates, arachi¬ donic acid, cyclic AMP and with the opening of ionic channels (reviewed in 1). The recent cloning of five different subtypes of muscarinic acetylcho¬ line receptors (defined ml-m5) has made it possi¬ ble to express the individual clones in cells lacking the muscarinic receptors (2) (3) (4) . This approach has been instrumental in analysing the type of coupling between each receptor and adenylyl cyclase, phos¬ pholipase C and phospholipase A2 (producing cAMP, inositol phosphates and arachidonic acid, respectively) (2) (3) (4) . It has been shown that the re¬ ceptors encoded by the m 1, m3 and m5 clones stim¬ ulate the adenylyl cyclase, phospholipase C and phospholipase A2 activity and that they are sensi¬ tive to the classic Ml antagonist pirenzepine (the affinity being highest for ml» m3-m5) (2-4). The receptors encoded by the m2 and m4 clones do not interact with phospholipase A2, activate very poorly phospholipase C, inhibit the adenylyl cyclase activ¬ ity, and are pirenzepine-insensitive (2) (3) (4) .
In the thyroid, the cholinergic system has been proposed to play a role in the control of thyroid hormone formation (5) (6) (7) . In the dog thyroid the muscarinic regulation of iodide organification has been related to the stimulation of phospholipase C activity (8) (9) (10) .
We have recently reported that in FRTL-5 cells, a continuous line derived from normal rat thyroid, a pirenzepine-insensitive muscarinic receptor is able to decrease the phospholipase C activity via an inhibitory GTP binding (G) protein directly inter¬ acting with the enzyme (11) . In these cells TSH and norepinephrine activate phospholipase C and phospholipase A2 (12) (13) (14) (15) (16) (17) (18) . Thyroid functions such as the efflux of iodide and the iodination of thy¬ roglobulin are controlled by the intracellular in¬ creases in Ca + and arachidonic acid that follow the activation of phospholipase C and A2, respectively (17) (18) (19) (20) (21) . Since 
Binding assay
A slight modification of a described procedure was em¬ ployed (27) . Membranes (29) .
Arachidonic acid release
The arachidonic acid release from monolayers of FRTL-5 cells was evaluated as previously reported (14) . Cells (Fig. 1) . The maximal effect was ob¬ served 5 min after the agonist addition (Fig. 1) . The dose-response curve was bell-shaped, and the max¬ imal effective concentration was 1 rimol/1 (Fig. 1) . The muscarinic antagonists atropine, pirenzepine, AFDX-116 and DAMP inhibited the carbachol-induced arachidonic acid release (Fig. 2) . The mu¬ scarinic receptor involved in the activation of phos¬ pholipase A2 in FRTL-5 cells is therefore sensitive to pirenzepine (Fig. 2) and it can be distinguished from the inhibitory receptor coupled to phospho¬ lipase C that is pirenzepine-insensitive (11 (Fig. 3) . This indicates that only upon prolonged pretreatments with the toxin all the G protein isoforms present in this system are inactivated ( Fig. 3) cordingly, the muscarinic and the adrenergic stim¬ ulation of the arachidonic acid release were addi¬ tive in this system even at the maximal effective doses of the two agonists (Fig. 4) .
Cyclic AMP levels Cholinergic agonists have been shown to modulate the adenylyl cyclase activity in several cell systems (1) . In FRTL-5 cells carbachol did not affect the basal levels of cAMP, whereas it potentiated the TSH-induced cAMP accumulation (Fig. 5) . The muscarinic antagonist DAMP inhibited by 70% the carbachol-induced potentiation of the TSH stimu¬ lus, whereas AFDX-116 did not affect it (data not shown). Both compounds were used at 0.1-10 nmol/1. Autoradiographic analysis of ADP-ribosylated G proteins in FRTL-5 cell membranes. Cells were incubated for the indicated times with 240 ng/1 pertussis toxin (PT). Membranes were prepared and the ADP ribosylation assay was performed as specified under Materials and Methods either in the absence (lanes [1] [2] [3] [4] (Fig. 6, panel B (14, 15, 17, 19) . The increase in cytosolic Ca2+ caused by the activation of phospholi¬ pase C accompanies the arachidonic acid release and has a role in the regulation of thyroid function (13, 14, 17, 18) . The activations of phospholipase A2 and C by the adrenergic agonists and TSH are sep¬ arate phenomena involving different G proteins (14, 15, 17, 33) .
Our data indicate that the cholinergic regulation of the FRTL-5 cells involves at least two separate mechanisms related to two receptors, a pirenzepine-sensitive receptor activating phospholipase A2 and a pirenzepine-insensitive receptor inhibiting phospholipase C, as also described previously (11 (33, 36, 37 (11, 15, 17, 18, 33) . Phospholipase A2 is coupled to the TSH and adrenergic receptors via G proteins highly sensitive to pertussis toxin, and to the mu-scarinic receptor via a G protein with low sensitivity to the toxin (this report and Ref. 17, 18, 33 
